Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week
J Harrington, JP Piccini, JH Alexander… - Journal of the American …, 2023 - jacc.org
Abstract Factor XI/XIa (FXI/FXIa) represents a potential target for improved precision in
anticoagulation because it is involved primarily in thrombus formation and plays a much …
anticoagulation because it is involved primarily in thrombus formation and plays a much …
[HTML][HTML] Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week
J Harrington, JP Piccini, JH Alexander… - Journal of the American …, 2023 - Elsevier
Abstract Factor XI/XIa (FXI/FXIa) represents a potential target for improved precision in
anticoagulation because it is involved primarily in thrombus formation and plays a much …
anticoagulation because it is involved primarily in thrombus formation and plays a much …
Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week
J Harrington, JP Piccini… - Journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Factor XI/XIa (FXI/FXIa) represents a potential target for improved precision in
anticoagulation because it is involved primarily in thrombus formation and plays a much …
anticoagulation because it is involved primarily in thrombus formation and plays a much …
Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week.
J Harrington, JP Piccini, JH Alexander… - Journal of the …, 2023 - europepmc.org
Factor XI/XIa (FXI/FXIa) represents a potential target for improved precision in
anticoagulation because it is involved primarily in thrombus formation and plays a much …
anticoagulation because it is involved primarily in thrombus formation and plays a much …